Impel NeuroPharma Closes $67.5 Million Series D to Advance CNS Portfolio

, , , , , , , , , ,

Seattle-based Impel NeuroPharma closed on a Series D financing totaling $67.5 million, co-led by KKR and Northwest Venture Partners.

Read more
/by